These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 1969915

  • 21. Carbamazepine decreases catecholamine turnover in the rat brain.
    Waldmeier PC, Baumann PA, Fehr B, De Herdt P, Maitre L.
    J Pharmacol Exp Ther; 1984 Oct; 231(1):166-72. PubMed ID: 6491972
    [Abstract] [Full Text] [Related]

  • 22. Secretion of dopa in phaeochromocytoma.
    Louis WJ, Doyle AE, Heath WC, Robinson MJ.
    Br Med J; 1972 Nov 11; 4(5836):325-7. PubMed ID: 4637512
    [Abstract] [Full Text] [Related]

  • 23. [Effect of a test with 0.1 g of L-DOPA on the dynamics of urinary excretion of catecholamines and DOPA in schizophrenic patients].
    Vasil'ev VN.
    Vopr Med Khim; 1980 Nov 11; 26(6):782-6. PubMed ID: 6779421
    [Abstract] [Full Text] [Related]

  • 24. Evaluation of neurotropic drug actions on tyrosine hydroxylase activity and dopamine metabolism in clonal cell lines.
    Bräutigam M, Kittner B, Herken H.
    Arzneimittelforschung; 1985 Nov 11; 35(1A):277-84. PubMed ID: 2859029
    [Abstract] [Full Text] [Related]

  • 25. Neuronal source of plasma dihydroxyphenylalanine.
    Goldstein DS, Udelsman R, Eisenhofer G, Stull R, Keiser HR, Kopin IJ.
    J Clin Endocrinol Metab; 1987 Apr 11; 64(4):856-61. PubMed ID: 3102548
    [Abstract] [Full Text] [Related]

  • 26. [Effect of alpha-methyl-paratyrosine on the urinary excretion of catecholamines in patients with pheochromocytoma].
    Rivero Sánchez M, Selgas Gutiérrez R, Lorenzo Aguiar MD, Martínez Muñoz I, Beberide García JM, Almaraz Jiménez M, Rińon Aguilar C, Sánchez Sicilia L.
    Rev Clin Esp; 1981 May 31; 161(4):235-9. PubMed ID: 7280330
    [No Abstract] [Full Text] [Related]

  • 27. Pheochromocytoma: urinary catecholamine excretion and insulin secretion after -methyl-p-tyrosine treatment.
    Parra A, Porcayo F, Santos D.
    Helv Paediatr Acta; 1972 Jul 31; 27(3):309-14. PubMed ID: 4645656
    [No Abstract] [Full Text] [Related]

  • 28. Regulation of catecholamine biosynthesis in a transplantable rat pheochromocytoma.
    Chalfie M, Perlman RL.
    J Pharmacol Exp Ther; 1977 Mar 31; 200(3):588-97. PubMed ID: 15098
    [Abstract] [Full Text] [Related]

  • 29. Reversibility of catecholamine-induced dilated cardiomyopathy in a child with a pheochromocytoma.
    Imperato-McGinley J, Gautier T, Ehlers K, Zullo MA, Goldstein DS, Vaughan ED.
    N Engl J Med; 1987 Mar 26; 316(13):793-7. PubMed ID: 2881206
    [No Abstract] [Full Text] [Related]

  • 30. Childhood pheochromocytoma: treatment with alpha methyl tyrosine for resistant hypertension.
    Robinson RG, DeQuattro V, Grushkin CM, Lieberman E.
    J Pediatr; 1977 Jul 26; 91(1):143-7. PubMed ID: 17659
    [Abstract] [Full Text] [Related]

  • 31. [The brain catecholamine systems in the regulation of dominance].
    Serova LI, Naumenko EV.
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1990 Jul 26; 40(3):490-6. PubMed ID: 1975967
    [Abstract] [Full Text] [Related]

  • 32. Failure of alpha-methyltyrosine to prevent hypertensive crisis in pheochromocytoma.
    Ram CV, Meese R, Hill SC.
    Arch Intern Med; 1985 Nov 26; 145(11):2114-5. PubMed ID: 2865938
    [Abstract] [Full Text] [Related]

  • 33. alpha-Methyl-p-tyrosine: a review of its pharmacology and clinical use.
    Brogden RN, Heel RC, Speight TM, Avery GS.
    Drugs; 1981 Feb 26; 21(2):81-9. PubMed ID: 7009139
    [Abstract] [Full Text] [Related]

  • 34. Metabolism of alpha-methyltyrosine in man: relationship to its potency as an inhibitor of catecholamine biosynthesis.
    Engelman K, Jéquier E, Udenfriend S, Sjoerdsma A.
    J Clin Invest; 1968 Mar 26; 47(3):568-76. PubMed ID: 5637144
    [Abstract] [Full Text] [Related]

  • 35. Excretion of catecholamines and metabolites in response to increased dietary phosphate intake.
    Berndt TJ, MacDonald A, Walikonis R, Chinnow S, Dousa TP, Tyce GM, Knox FG.
    J Lab Clin Med; 1993 Jul 26; 122(1):80-4. PubMed ID: 8320494
    [Abstract] [Full Text] [Related]

  • 36. Tyrosine hydroxylase in human adrenal and pheochromocytoma: localization, kinetics, and catecholamine inhibition.
    Waymire JC, Weiner N, Schneider FH, Goldstein M, Freedman LS.
    J Clin Invest; 1972 Jul 26; 51(7):1798-804. PubMed ID: 4402349
    [Abstract] [Full Text] [Related]

  • 37. Catecholamine content and in vitro catecholamine synthesis in peripheral human lymphocytes.
    Musso NR, Brenci S, Setti M, Indiveri F, Lotti G.
    J Clin Endocrinol Metab; 1996 Oct 26; 81(10):3553-7. PubMed ID: 8855800
    [Abstract] [Full Text] [Related]

  • 38. Decreased tyrosine hydroxylase activity in the adrenals of spontaneously hypertensive rats.
    Moura E, Pinho Costa PM, Moura D, Guimarães S, Vieira-Coelho MA.
    Life Sci; 2005 May 06; 76(25):2953-64. PubMed ID: 15820506
    [Abstract] [Full Text] [Related]

  • 39. [L-DOPA test for evaluating in vivo catecholamine biosynthesis in normal persons and persons with different diseases].
    Vasil'ev VN, Matlina ESh.
    Vopr Med Khim; 1977 May 06; (3):332-8. PubMed ID: 888397
    [Abstract] [Full Text] [Related]

  • 40. Abnormal catecholamine metabolism in pheochromocytoma.
    Rubio MC, Barontini MB.
    Medicina (B Aires); 1985 May 06; 45(6):631-6. PubMed ID: 2878347
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.